PSA doubling time: Solid predictor of PCa survival

New Orleans--PSA doubling time (PSADT) appears to be a strong predictor of the probability of distant metastasis and prostate cancer-specific survival in men with biochemical relapse after radical prostatectomy, according to Mario A. Eisenberger, MD.

Related Videos

Related Content

Advertisement

April 25th 2025

FDA clears AI-powered application for measuring prostate volume

Benjamin P. Saylor

Clarius Mobile Health said it will be demonstrating the application at the AUA Annual Meeting in Las Vegas, Nevada.

April 24th 2025

Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MD

Amy M. Pearlman, MD Brian L. Steixner, MD

Host Amy Pearlman, MD, discusses premature ejaculation with Brian L. Steixner, MD, a board-certified urologist in Linwood, New Jersey.

April 24th 2025

First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI

Hannah Clarke

"What is truly exciting is the potential for this device to meaningfully improve early and long-term continence rates, which can profoundly impact a patient's recovery and overall quality of life,” says Patrick Daily, MD.

April 21st 2025

Introducing Pearls & Perspectives, with Amy Pearlman, MD!

Amy M. Pearlman, MD

Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.

April 23rd 2025

Conference Preview: American Urological Association 2025

Hannah Clarke

View slated interviews with experts as well as insights from urologists on what to watch for.

April 23rd 2025

Study shows IsoPSA’s predictive ability for clinically significant prostate cancer

Hannah Clarke

"In this large study of over 1500 men with an elevated PSA, we found that a low IsoPSA is incredibly reassuring,” says Christopher J. Weight, MD.

Related Content

Advertisement

April 25th 2025

FDA clears AI-powered application for measuring prostate volume

Benjamin P. Saylor

Clarius Mobile Health said it will be demonstrating the application at the AUA Annual Meeting in Las Vegas, Nevada.

April 24th 2025

Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MD

Amy M. Pearlman, MD Brian L. Steixner, MD

Host Amy Pearlman, MD, discusses premature ejaculation with Brian L. Steixner, MD, a board-certified urologist in Linwood, New Jersey.

April 24th 2025

First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI

Hannah Clarke

"What is truly exciting is the potential for this device to meaningfully improve early and long-term continence rates, which can profoundly impact a patient's recovery and overall quality of life,” says Patrick Daily, MD.

April 21st 2025

Introducing Pearls & Perspectives, with Amy Pearlman, MD!

Amy M. Pearlman, MD

Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.

April 23rd 2025

Conference Preview: American Urological Association 2025

Hannah Clarke

View slated interviews with experts as well as insights from urologists on what to watch for.

April 23rd 2025

Study shows IsoPSA’s predictive ability for clinically significant prostate cancer

Hannah Clarke

"In this large study of over 1500 men with an elevated PSA, we found that a low IsoPSA is incredibly reassuring,” says Christopher J. Weight, MD.